0.00Open0.03Pre Close0 Volume44 Open Interest88.00Strike Price0.00Turnover1716.35%IV10.58%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type0.0225Delta0.0148Gamma2653.67Leverage Ratio-35.4207Theta0.0000Rho59.83Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet